Clinical Trial Update: ICULIP, Influence of Two Lipid Emulsions in the Nosocomial Infection in Critical Patients [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluating two lipid emulsions for preventing nosocomial infection in critically ill patients has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Critical Illness

Drugs mentioned

• lipid emulsion A
• lipid emulsion B

Snippet

Sponsor: B. Braun Medical SA | Conditions: Critical Illness | Phase 4 | Status: TERMINATED